Enzalutamide Before Surgery in Treating Patients With Kidney Cancer
Status:
Terminated
Trial end date:
2020-03-02
Target enrollment:
Participant gender:
Summary
This pilot phase 0 trial studies how well enzalutamide works before surgery in treating
patients with kidney cancer. Androgens are a type of hormone produced by the body that may
cause kidney tumors to grow. Anti-hormone therapy, such as enzalutamide, may lessen the
amount of androgens produced by the body and keep kidney tumors from growing.